Rinsho Ketsueki
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
Case Reports
Successful delivery after chemotherapy for acute myeloid leukemia diagnosed in the second trimester
Yuka YANAIKuniko TAKANOKentaro NAGAMATSUMasanori SAKATAOju KATAYAMANatsumi YOSHIDAShuhei HONDARie KAWANOMasao OGATATaisuke MORITAYoshihiro NISHIDAHisashi NARAHARAKuniaki SHIRAO
Author information
JOURNAL RESTRICTED ACCESS

2020 Volume 61 Issue 3 Pages 228-233

Details
Abstract

Development of acute myeloid leukemia (AML) during pregnancy is rare, and the available data are limited to small retrospective reports. Currently, no guidelines exist for the management of AML during pregnancy in Japan. A 26-year-old female was diagnosed with AML at 19 weeks of gestation, received chemotherapy with daunorubicin and cytarabine, and achieved complete remission. Following the first consolidation therapy, she gave birth to a 1964-g female infant by cesarean section at 33 weeks of gestation. One week later, she was initiated on the second consolidation therapy; however, she developed a pelvic abscess during neutropenia. She underwent urgent surgery for open drainage and recovered soon after surgery. She has been in complete remission for eight months, and the daughter is healthy. Chemotherapy delivered after the second trimester rarely causes congenital malformations and may not require the termination of pregnancy. The clinical course of the present case suggests that chemotherapy can be performed safely and effectively in pregnant patients with AML after the trimester and babies.

Content from these authors
© 2020 The Japanese Society of Hematology
Previous article Next article
feedback
Top